These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26208484)

  • 1. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
    Forghani P; Waller EK
    Breast Cancer Res Treat; 2015 Aug; 153(1):21-30. PubMed ID: 26208484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
    Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
    J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
    Shime H; Kojima A; Maruyama A; Saito Y; Oshiumi H; Matsumoto M; Seya T
    J Innate Immun; 2014; 6(3):293-305. PubMed ID: 24192491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
    Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
    Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
    Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA
    Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
    Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
    Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells in breast cancer.
    Markowitz J; Wesolowski R; Papenfuss T; Brooks TR; Carson WE
    Breast Cancer Res Treat; 2013 Jul; 140(1):13-21. PubMed ID: 23828498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth.
    Wang X; Wang X; Wang D; Zhou C; Lv K; Ma Y; Chang W; Wang B; Hu J; Ji Y; Dai Z; Ma Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113089. PubMed ID: 39244897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1.
    Zalba S; Belsúe V; Topp B; de Alwis D; Alvarez M; Trocóniz IF; Berraondo P; Garrido MJ
    Br J Cancer; 2021 Mar; 124(7):1275-1285. PubMed ID: 33531689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mn complex-mediated enhancement of antitumor response through modulating myeloid-derived suppressor cells in drug-resistant tumor.
    Das S; Banerjee K; Roy S; Majumder S; Chatterjee M; Majumdar S; Choudhuri SK
    In Vivo; 2014; 28(5):909-18. PubMed ID: 25189907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
    Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S
    Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
    Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.